These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2612084)

  • 1. Low-dose methotrexate in systemic onset juvenile chronic arthritis.
    Speckmaier M; Findeisen J; Woo P; Hall A; Sills JA; Price T; Hollingworth P; Craft A; Ansell BM
    Clin Exp Rheumatol; 1989; 7(6):647-50. PubMed ID: 2612084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.
    Ravelli A; Gerloni V; Corona F; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano CG; Alessio M; Fantini F; Bardare M; Martini A
    Clin Exp Rheumatol; 1998; 16(2):181-3. PubMed ID: 9536397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
    Chickermane PR; Khubchandani RP
    Clin Exp Rheumatol; 2015; 33(2):287-92. PubMed ID: 25738527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Maximov A; Vorontsov I; Fink CW; Newman AJ; Cassidy JT; Zemel LS
    N Engl J Med; 1992 Apr; 326(16):1043-9. PubMed ID: 1549149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis.
    Wallace CA; Bleyer WA; Sherry DD; Salmonson KL; Wedgwood RJ
    Arthritis Rheum; 1989 Jun; 32(6):677-81. PubMed ID: 2735961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis.
    Reiff A; Shaham B; Wood BP; Bernstein BH; Stanley P; Szer IS
    Clin Exp Rheumatol; 1995; 13(1):113-8. PubMed ID: 7774090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis.
    Shetty AK; Zganjar BE; Ellis GS; Ludwig IH; Gedalia A
    J Pediatr Ophthalmol Strabismus; 1999; 36(3):125-8. PubMed ID: 10358815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.
    Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P
    Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept in systemic juvenile idiopathic arthritis.
    Russo RA; Katsicas MM; Zelazko M
    Clin Exp Rheumatol; 2002; 20(5):723-6. PubMed ID: 12412209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating etanercept in a once weekly dose in children with juvenile idiopathic arthritis.
    Prince FH; van Suijlekom-Smit LW
    Rheumatol Int; 2008 Feb; 28(4):397-8, author reply 399. PubMed ID: 17940772
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
    Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
    J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte-methotrexate and disease activity in children treated with oral methotrexate for juvenile chronic arthritis.
    Kristensen K; Nielsen S; Karup Pedersen F; Zak M
    Scand J Rheumatol; 2000; 29(3):187-9. PubMed ID: 10898073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of methotrexate therapy for juvenile rheumatoid arthritis.
    Lin YT; Tsai MJ; Wang LH; Huang MT; Yang YH; Chiang BL
    J Formos Med Assoc; 2000 Aug; 99(8):623-9. PubMed ID: 10969505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype.
    Halle F; Prieur AM
    Clin Exp Rheumatol; 1991; 9(3):297-302. PubMed ID: 1879091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
    Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
    Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis.
    Rose CD; Singsen BH; Eichenfield AH; Goldsmith DP; Athreya BH
    J Pediatr; 1990 Oct; 117(4):653-9. PubMed ID: 2213397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study.
    Huemer M; Födinger M; Huemer C; Sailer-Höck M; Falger J; Rettenbacher A; Bernecker M; Artacker G; Kenzian H; Lang T; Stöckler-Ipsiroglu S
    Clin Exp Rheumatol; 2003; 21(2):249-55. PubMed ID: 12747286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.
    Leiskau C; Thon A; Gappa M; Dressler F
    Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.